James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Humana Inc (HUM), Fortinet Inc (FTNT) and Telefonaktiebolaget LM Ericsson (ERIC) Are 3 of Today’s Worst Stocks

Ericsson (ERIC), Humana (HUM) and Fortinet (FTNT) were taken out behind the woodshed on Wednesday. Here's what you need to know.

Don’t Read Too Much Into Humana Inc’s (HUM) Lowered Medicare Rating

Health insurer Humana (HUM) is down on diminished government approval, but the attempt to merge with Aetna is still the big story to watch.

The Pain Is Only Beginning for Samsung Electronics (SSNLF) Stock

Samsung (SSNLF) stock may have just become very tough to own, even if the company has yet to quantify its latest heap of trouble.

Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full.

Why Alcoa Inc (AA), Illumina, Inc. (ILMN) and Seagate Technology PLC (STX) Are 3 of Today’s Worst Stocks

Illumina (ILMN), Alcoa (AA) and Seagate Technology (STX) all helped set a bearish tone to Q3's earnings season.